Edward Wadie, DPM
Foot & Ankle Surgery · Liverpool, NYNPI 1184810434
Payments from drug & device makers
Across 90 payments — averaging $44.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$906
- Paratek Pharmaceuticals, Inc.$563
- Treace Medical Concepts, Inc.$370
- AbbVie$235
- Amgen$224
- Mimedx Group, Inc.$215
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,986100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 14 | $906 |
| Paratek Pharmaceuticals, Inc. | 19 | $563 |
| Treace Medical Concepts, Inc. | 4 | $370 |
| AbbVie | 3 | $235 |
| Amgen | 3 | $224 |
| Mimedx Group, Inc. | 9 | $215 |
| Smith+Nephew | 12 | $207 |
| Johnson & Johnson | 2 | $129 |
| Advanced Oxygen Therapy Inc. | 2 | $129 |
| Integra Lifesciences Corporation | 1 | $128 |
| Trilliant Surgical LLC. | 1 | $120 |
| Nevro Corp. | 1 | $114 |
| KCI USA, Inc. | 1 | $106 |
| Aroa Biosurgery Incorporated | 2 | $103 |
| Acell, Inc. | 1 | $90 |
| Averitas Pharma Inc. | 3 | $71 |
| Biocomposites Inc | 1 | $62 |
| Convatec Inc. | 2 | $50 |
| Bioventus LLC | 2 | $36 |
| Davol Inc. | 1 | $27 |
| Merck | 2 | $27 |
| Zimmer Biomet | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$371
- NUZYRA$235
- Lapiplasty System$221
- BILAYER WOUND MATRIX (BWM)$128
- INTEGRA WOUND MATRIX (IWM)$128
- PRIMATRIX$128
- IDRT$128
- FLOWABLE$128
- DALVANCE$125
- PURAPLY WOUND MATRIX$120
- Arsenal Sinus Support Plate$120
- KRYSTEXXA$115
- TFN ADVANCED$114
- EXPAREL$114
- Omnia$114
- SNAP$106
- ACTIVAC$106
- VAC VERAFLO CLEANSE CHOICE$106
- PREVENA$106
- VAC VERAFLO$106
How this compares
$3,986 in reported general payments places this provider in the 65th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Liverpool
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4.1M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$644K
- John KennedyNew York$613K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$365K
- Edward AzarBrooklyn$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.